Aptevo Therapeutics Inc.

SEATTLE, WA · CIK 0001671584 · Biotech · Private

Bispecific and trispecific immunotherapies for cancer treatment

aptevotherapeutics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$5.6M
2 Form D · Aug 2026
2 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$2,100,004
Private capital raisedForm D · SEC$3,472,683
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1466GC Therapeutics——
1467Endogenex, Inc.—$122M
1468Nob Hill Therapeutics, Inc.—$2.2M
1469Aptevo Therapeutics Inc.—$5.6M
1470Up Therapeutics LLC——
1471CALIFORNIA STEM CELL INC—$1.9M
1472Aptorum Group Ltd—$1.6M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Marvin WhiteDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.